Article in Science advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
8 citing papers in PubMed, 8 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
18 authors at 6 institutions in 4 countries.
Shaheen S SikandarDepartment of Molecular, Cell and Developmental Biology, University of California, Santa Cruz, Santa Cruz, CA 95064, USA.ORCID 0000-0003-1867-6378
Gunsagar S GulatiInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, 265 Campus Drive, School of Medicine, Stanford, CA 94305, USA.
Jane AntonyInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, 265 Campus Drive, School of Medicine, Stanford, CA 94305, USA.ORCID 0000-0002-2424-5470
Isobel FetterDepartment of Molecular, Cell and Developmental Biology, University of California, Santa Cruz, Santa Cruz, CA 95064, USA.ORCID 0000-0002-6021-2713
Angera H KuoInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, 265 Campus Drive, School of Medicine, Stanford, CA 94305, USA.ORCID 0000-0001-6955-9951
William Hai Dang HoInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, 265 Campus Drive, School of Medicine, Stanford, CA 94305, USA.ORCID 0000-0003-1365-9624
Veronica Haro-AcostaDepartment of Molecular, Cell and Developmental Biology, University of California, Santa Cruz, Santa Cruz, CA 95064, USA.ORCID 0000-0003-4836-9686
Soumyashree DasDepartment of Biology, Stanford University, Stanford, CA 94305, USA.
Chloé B SteenDivision of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, CA, USA.ORCID 0000-0001-7290-7128
Thiago Almeida PereiraInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, 265 Campus Drive, School of Medicine, Stanford, CA 94305, USA.ORCID 0000-0002-8755-0683
Dalong QianInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, 265 Campus Drive, School of Medicine, Stanford, CA 94305, USA.ORCID 0000-0002-6261-5188
Philip A BeachyInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, 265 Campus Drive, School of Medicine, Stanford, CA 94305, USA.ORCID 0000-0003-1098-9046
Frederick M DirbasDepartment of Surgery, Stanford Cancer Institute, Stanford University School of Medicine, 875 Blake Wilbur Drive, Rm CC2235, Stanford, CA 94305, USA.ORCID 0000-0003-3576-6404
Kristy Red-HorseInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, 265 Campus Drive, School of Medicine, Stanford, CA 94305, USA.ORCID 0000-0003-1541-601X
Terence H RabbittsDivision of Cancer Therapeutics, Institute of Cancer Research, London SM2 5NG, UK.ORCID 0000-0002-4982-2609
Jean Paul ThieryGuangzhou Laboratory, International Biological Island, Guangzhou, Guangdong 510005, China.
Aaron M NewmanInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, 265 Campus Drive, School of Medicine, Stanford, CA 94305, USA.ORCID 0000-0002-1857-8172
Michael F ClarkeInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, 265 Campus Drive, School of Medicine, Stanford, CA 94305, USA.ORCID 0000-0001-6889-4926
California Institute for Regenerative Medicine · USStanford University · USUniversity of California, Santa Cruz · USGuangzhou Experimental Station · CNHoward Hughes Medical Institute · USInstitute of Cancer Research · GB
Funding
Leveraging innovative technologies in basic and clinical cancer researchT32CA009302 · NCI · STANFORD UNIVERSITY · PI LAURA D ATTARDI, Aaron M Newman · 1985 to 2026
$19.1M
therapeutic Targeting of CD47 on Human Leukemia and Other Cancer Stem CellsP01CA139490 · NCI · STANFORD UNIVERSITY · PI CLARKE, MICHAEL · 2009 to 2013
$8.7M
VECTOR COREP30NS069375 · NINDS · STANFORD UNIVERSITY · PI SHAMLOO, MEHRDAD · 2011 to 2019
$6.3M
Mechanotransduction and transcriptional regulation during artery developmentR01HL128503 · NHLBI · STANFORD UNIVERSITY · PI Mary Red-Horse · 2015 to 2026
$5.8M
Training Program in Molecular, Cell, and Developmental BiologyT32GM133391 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI Needhi Bhalla · 2019 to 2026
$3.0M
Self-Renewal of Normal and Leukemic Stem CellsR01CA100225 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CLARKE, MICHAEL · 2004 to 2015
$2.9M
Delineating developmental programs driving tumorigenesis in triple-negative breast cancerR01CA255450 · NCI · STANFORD UNIVERSITY · PI NEWMAN, AARON M · 2021 to 2025
$2.5M
Cellular hierachy of ER- breast cancers in different ethnic groupsU01CA154209 · NCI · STANFORD UNIVERSITY · PI CLARKE, MICHAEL · 2010 to 2014
$2.5M
Ultrasensitive Quantitation of Circulating Tumor DNAR00CA187192 · NCI · STANFORD UNIVERSITY · PI NEWMAN, AARON M · 2017 to 2019
$747k
Ultrasensitive Quantitation of Circulating Tumor DNAK99CA187192 · NCI · STANFORD UNIVERSITY · PI NEWMAN, AARON M · 2015 to 2016
Metastasis is responsible for most breast cancer-related deaths; however, identifying the cellular determinants of metastasis has remained challenging. Here, we identified a minority population of immature
Indexed as
Breast NeoplasmsLung NeoplasmsAdaptor Proteins, Signal TransducingAnimalsFemaleHumansLIM Domain ProteinsMiceProto-Oncogene ProteinsSignal TransductionAdaptor Proteins, Signal TransducingLIM Domain ProteinsLMO2 protein, humanProto-Oncogene Proteins
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Identification of a minority population of LMO2 · full record | OpenQuestion